{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T18:39:01Z","timestamp":1789843141186,"version":"4.0.1"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T00:00:00Z","timestamp":1769558400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","resmedjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Respiratory Medicine"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.rmed.2026.108681","type":"journal-article","created":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T16:09:45Z","timestamp":1769616585000},"page":"108681","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Eligibility for biological treatments in COPD patients experiencing a severe COPD exacerbation"],"prefix":"10.1016","volume":"253","author":[{"given":"Stavroula","family":"Zaneli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8933-6800","authenticated-orcid":false,"given":"Agamemnon","family":"Bakakos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9657-3705","authenticated-orcid":false,"given":"Konstantinos","family":"Bartziokas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anastasia","family":"Papaporfyriou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyriaki","family":"Cholidou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4925-2332","authenticated-orcid":false,"given":"Nektarios","family":"Anagnostopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4444-0967","authenticated-orcid":false,"given":"Georgios","family":"Zakynthinos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8079-0599","authenticated-orcid":false,"given":"Evangelos","family":"Oikonomou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-5794-3089","authenticated-orcid":false,"given":"Angelos","family":"Vontetsianos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9595-6974","authenticated-orcid":false,"given":"Nikolaos","family":"Chynkiamis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-0925-4046","authenticated-orcid":false,"given":"Christina","family":"Anagnostopoulou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikoletta","family":"Rovina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9256-9656","authenticated-orcid":false,"given":"Petros","family":"Bakakos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9708-3241","authenticated-orcid":false,"given":"Andriana I.","family":"Papaioannou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.rmed.2026.108681_bib1","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1164\/rccm.200912-1843CC","article-title":"Chronic obstructive pulmonary disease phenotypes: the future of COPD","volume":"182","author":"Han","year":"2010","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"9485","key":"10.1016\/j.rmed.2026.108681_bib2","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/S0140-6736(05)67100-0","article-title":"Roflumilast--an oral anti-inflammatory treatment for chronic obstructive pulmonary disease: a randomised controlled trial","volume":"366","author":"Rabe","year":"2005","journal-title":"Lancet"},{"issue":"9971","key":"10.1016\/j.rmed.2026.108681_bib3","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/S0140-6736(14)62410-7","article-title":"Effect of roflumilast on exacerbations in patients with severe chronic obstructive pulmonary disease uncontrolled by combination therapy (REACT): a multicentre randomised controlled trial","volume":"385","author":"Martinez","year":"2015","journal-title":"Lancet"},{"issue":"24","key":"10.1016\/j.rmed.2026.108681_bib5","doi-asserted-by":"crossref","first-page":"2274","DOI":"10.1056\/NEJMoa2401304","article-title":"Dupilumab for COPD with blood eosinophil evidence of type 2 inflammation","volume":"390","author":"Bhatt","year":"2024","journal-title":"N. Engl. J. Med."},{"issue":"3","key":"10.1016\/j.rmed.2026.108681_bib6","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1056\/NEJMoa2303951","article-title":"Dupilumab for COPD with type 2 inflammation indicated by eosinophil counts","volume":"389","author":"Bhatt","year":"2023","journal-title":"N. Engl. J. Med."},{"issue":"8","key":"10.1016\/j.rmed.2026.108681_bib7","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1056\/NEJMoa1104623","article-title":"Azithromycin for prevention of exacerbations of COPD","volume":"365","author":"Albert","year":"2011","journal-title":"N. Engl. J. Med."},{"issue":"3","key":"10.1016\/j.rmed.2026.108681_bib8","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1164\/rccm.202107-1663SO","article-title":"Treatment trials in young patients with chronic obstructive pulmonary disease and pre-chronic obstructive pulmonary disease patients: time to move forward","volume":"205","author":"Martinez","year":"2022","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"10","key":"10.1016\/j.rmed.2026.108681_bib9","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1136\/thorax.57.10.847","article-title":"Relationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary disease","volume":"57","author":"Donaldson","year":"2002","journal-title":"Thorax"},{"issue":"4","key":"10.1016\/j.rmed.2026.108681_bib10","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1183\/09031936.00180312","article-title":"High-risk patients following hospitalisation for an acute exacerbation of COPD","volume":"42","author":"Piquet","year":"2013","journal-title":"Eur. Respir. J."},{"issue":"1","key":"10.1016\/j.rmed.2026.108681_bib11","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1164\/rccm.201711-2239OC","article-title":"Exacerbations of chronic obstructive pulmonary disease and cardiac events. A post hoc cohort analysis from the SUMMIT randomized clinical trial","volume":"198","author":"Kunisaki","year":"2018","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"6","key":"10.1016\/j.rmed.2026.108681_bib12","doi-asserted-by":"crossref","first-page":"2151","DOI":"10.1007\/s12325-024-02855-4","article-title":"Implications of cardiopulmonary risk for the management of COPD: a narrative review","volume":"41","author":"Singh","year":"2024","journal-title":"Adv. Ther."},{"key":"10.1016\/j.rmed.2026.108681_bib13","doi-asserted-by":"crossref","first-page":"427","DOI":"10.2147\/COPD.S346591","article-title":"Frequency and severity of exacerbations of COPD associated with future risk of exacerbations and mortality: a UK routine health care data study","volume":"17","author":"Whittaker","year":"2022","journal-title":"Int. J. Chronic Obstr. Pulm. Dis."},{"issue":"17","key":"10.1016\/j.rmed.2026.108681_bib16","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1056\/NEJMoa1708208","article-title":"Mepolizumab for eosinophilic chronic obstructive pulmonary disease","volume":"377","author":"Pavord","year":"2017","journal-title":"N. Engl. J. Med."},{"issue":"17","key":"10.1016\/j.rmed.2026.108681_bib17","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1056\/NEJMoa2413181","article-title":"Mepolizumab to prevent exacerbations of COPD with an eosinophilic phenotype","volume":"392","author":"Sciurba","year":"2025","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.rmed.2026.108681_bib18","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1186\/s12931-017-0559-0","article-title":"Clinical characteristics of eosinophilic COPD versus COPD patients with a history of asthma","volume":"18","author":"Kolsum","year":"2017","journal-title":"Respir. Res."},{"issue":"10","key":"10.1016\/j.rmed.2026.108681_bib19","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1164\/rccm.201701-0009LE","article-title":"Stability of blood eosinophils in patients with chronic obstructive pulmonary disease and in control subjects, and the impact of sex, age, smoking, and baseline counts","volume":"195","author":"Oshagbemi","year":"2017","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"6","key":"10.1016\/j.rmed.2026.108681_bib20","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1183\/09031936.00162414","article-title":"Eosinophilic inflammation in COPD: prevalence and clinical characteristics","volume":"44","author":"Singh","year":"2014","journal-title":"Eur. Respir. J."},{"issue":"12","key":"10.1016\/j.rmed.2026.108681_bib21","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1056\/NEJMoa0909883","article-title":"Susceptibility to exacerbation in chronic obstructive pulmonary disease","volume":"363","author":"Hurst","year":"2010","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.rmed.2026.108681_bib22","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1183\/09031936.00141611","article-title":"The chronic bronchitis phenotype in subjects with and without COPD: the PLATINO study","volume":"40","author":"de Oca","year":"2012","journal-title":"Eur. Respir. J."},{"issue":"5","key":"10.1016\/j.rmed.2026.108681_bib23","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01446-2016","article-title":"Phenotypes of COPD patients with a smoking history in central and Eastern Europe: the POPE study","volume":"49","author":"Koblizek","year":"2017","journal-title":"Eur. Respir. J."},{"issue":"8","key":"10.1016\/j.rmed.2026.108681_bib24","doi-asserted-by":"crossref","first-page":"992","DOI":"10.5588\/ijtld.15.0021","article-title":"Frequency and characteristics of different clinical phenotypes of chronic obstructive pulmonary disease","volume":"19","author":"Miravitlles","year":"2015","journal-title":"Int. J. Tubercul. Lung Dis."},{"key":"10.1016\/j.rmed.2026.108681_bib25","series-title":"Chronic Bronchitis, Treasure Island (FL)","author":"Widysanto","year":"2025"},{"key":"10.1016\/j.rmed.2026.108681_bib26","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.2147\/COPD.S294333","article-title":"Mepolizumab for eosinophil-associated COPD: analysis of METREX and METREO","volume":"16","author":"Pavord","year":"2021","journal-title":"Int. J. Chronic Obstr. Pulm. Dis."},{"issue":"4","key":"10.1016\/j.rmed.2026.108681_bib27","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1378\/chest.14-2535","article-title":"Determinants of underdiagnosis of COPD in national and international surveys","volume":"148","author":"Lamprecht","year":"2015","journal-title":"Chest"},{"issue":"6","key":"10.1016\/j.rmed.2026.108681_bib28","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00024-2020","article-title":"Population-based case-finding to identify subjects with undiagnosed asthma or COPD","volume":"55","author":"Preteroti","year":"2020","journal-title":"Eur. Respir. J."},{"issue":"6","key":"10.1016\/j.rmed.2026.108681_bib29","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1378\/chest.13-0453","article-title":"Characteristics of undertreatment in COPD in the general population","volume":"144","author":"Ingebrigtsen","year":"2013","journal-title":"Chest"},{"issue":"2","key":"10.1016\/j.rmed.2026.108681_bib30","doi-asserted-by":"crossref","DOI":"10.1183\/23120541.00584-2021","article-title":"Trends in non-receipt of recommended COPD medication","volume":"8","author":"Poon","year":"2022","journal-title":"ERJ Open Res"},{"key":"10.1016\/j.rmed.2026.108681_bib31","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.2147\/COPD.S398816","article-title":"Real-world treatment patterns and switching following moderate\/severe chronic obstructive pulmonary disease exacerbation in patients with commercial or medicare insurance in the United States","volume":"18","author":"Bogart","year":"2023","journal-title":"Int. J. Chronic Obstr. Pulm. Dis."},{"issue":"1","key":"10.1016\/j.rmed.2026.108681_bib32","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1038\/s41533-025-00448-4","article-title":"De-implementation of inappropriate inhaled corticosteroid use in patients with COPD in general practice, results of a mixed methods study","volume":"35","author":"van den Bemt","year":"2025","journal-title":"NPJ Prim Care Respir Med"},{"issue":"3","key":"10.1016\/j.rmed.2026.108681_bib33","article-title":"Effectiveness of roflumilast in treating chronic obstructive pulmonary disease: a systematic review and meta-analysis","volume":"14","author":"Naseem","year":"2022","journal-title":"Cureus"},{"key":"10.1016\/j.rmed.2026.108681_bib34","doi-asserted-by":"crossref","first-page":"813","DOI":"10.2147\/COPD.S154012","article-title":"Use of a 4-week up-titration regimen of roflumilast in patients with severe COPD","volume":"13","author":"Watz","year":"2018","journal-title":"Int. J. Chronic Obstr. Pulm. Dis."},{"issue":"4","key":"10.1016\/j.rmed.2026.108681_bib35","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2023-003583","article-title":"Anti-IL-5 biologics and rheumatoid arthritis: a single-centre 500 patient year exposure analysis","volume":"9","author":"Dean","year":"2023","journal-title":"RMD Open"},{"key":"10.1016\/j.rmed.2026.108681_bib36","article-title":"Dupilumab and lymphoma risk among patients with asthma: a population-based cohort study","author":"Sheng-Kai Ma","year":"2025","journal-title":"Eur. Respir. J."},{"issue":"2","key":"10.1016\/j.rmed.2026.108681_bib37","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.jaad.2024.03.039","article-title":"Dupilumab therapy for atopic dermatitis is associated with increased risk of cutaneous T cell lymphoma: a retrospective cohort study","volume":"91","author":"Hasan","year":"2024","journal-title":"J. Am. Acad. Dermatol."}],"container-title":["Respiratory Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0954611126000491?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0954611126000491?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,2,23]],"date-time":"2026-02-23T07:51:23Z","timestamp":1771833083000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0954611126000491"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":34,"alternative-id":["S0954611126000491"],"URL":"https:\/\/doi.org\/10.1016\/j.rmed.2026.108681","relation":{},"ISSN":["0954-6111"],"issn-type":[{"value":"0954-6111","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Eligibility for biological treatments in COPD patients experiencing a severe COPD exacerbation","name":"articletitle","label":"Article Title"},{"value":"Respiratory Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rmed.2026.108681","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"108681"}}